Concept Life Sciences

Concept Life Sciences (CLS) is a knowledge-based, science-led contract research organization. It offers a range of discovery and development services and analytical solutions across the pharmaceutical, biotechnology, food, agrochemical, petrochemical, chemical, cosmetics, and consumer products sectors. The company covers activities from target to clinic, including discovery chemistry, biology, DMPK, bioanalysis, toxicology, and GMP manufacturing. CLS also develops solutions focused on synthetic chemistry, analytical chemistry (GLP), ADMET services, and investigative and exploratory toxicology, including endocrine disruptors assays and expert support. In addition, the company operates food testing laboratories that provide a range of analytical services to the food industry covering pesticides, contaminants, micro-pollutants, microbiology, nutrition, and allergens.

Employee Rating

3More
TypeSubsidiary
Parent CompanyMalvern Panalytical
HQAlderley Edge, GB
Founded2014
Websiteconceptlifesciences.com
Cybersecurity ratingBMore
Concept Life Sciences was founded in 2014 and is headquartered in Alderley Edge, GB

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at Concept Life Sciences

Mark Carnegie-Brown

Mark Carnegie-Brown

President
Ben Cliff

Ben Cliff

VP Operations
Steven Woolley

Steven Woolley

Director of Analytical Services
Tilly Bingham

Tilly Bingham

VP of Science
Dave Leese

Dave Leese

VP Chemistry
David Leese

David Leese

VP Chemistry Services
Show more

Concept Life Sciences Office Locations

Concept Life Sciences has offices in Alderley Edge, Bar Hill, Bradford, Derbyshire and in 2 other locations
Alderley Edge, GB (HQ)
Alderley Park, Congleton Rd
Bar Hill, GB
Unit 1, The Links
Bradford, GB
20 Campus Rd
Derbyshire, GB
Frith Knoll Rd
Dundee, GB
2 James Lindsay Place, Dundee Technopole
Sandwich, GB
Discovery Park, Ramsgate Rd
Show all (6)

Concept Life Sciences Financials and Metrics

Summary Metrics

Founding Date

2014
Concept Life Sciences is a subsidiary of Malvern Panalytical

Concept Life Sciences Revenue

Concept Life Sciences's revenue was reported to be £46.84 m in FY, 2017 which is a 14% increase from the previous period.
GBPFY, 2017FY, 2018FY, 2019

Revenue

46.8m

Revenue growth, %

14%

Cost of goods sold

25.9m

Gross profit

20.9m
GBPFY, 2017FY, 2018FY, 2019

Cash

1.6m

Accounts Receivable

9.2m

Inventories

2.1m

Current Assets

17.2m63.4m63.1m
GBPFY, 2017

Net Income

(5.9m)

Depreciation and Amortization

3.5m

Accounts Payable

(326.3k)

Cash From Operating Activities

1.0m
GBPFY, 2017

Revenue/Employee

261.2k

Debt/Equity

-5.5 x

Debt/Assets

1 x

Financial Leverage

-5.5 x
Show all financial metrics

Concept Life Sciences Operating Metrics

Dec, 2020

Industries Served

3
Show all operating metrics

Concept Life Sciences Acquisitions / Subsidiaries

Company NameDateDeal Size
Aquila BioMedicalOctober 30, 2017
Scientific Analysis LaboratoriesJuly 07, 2017
Agenda1 Analytical ServicesOctober 20, 2015
CXR BiosciencesAugust 18, 2015
Peakdale MolecularJuly 07, 2014
Resource & Environmental ConsultantsJuly 07, 2014

Concept Life Sciences Revenue Breakdown

Embed Graph

Concept Life Sciences revenue breakdown by geographic segment: 67.7% from United Kingdom and 32.3% from Rest of the world

Human Capital Metrics

Embed Graph
Show all human capital metrics

Concept Life Sciences Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

SecurityScorecard logo

Concept Life Sciences Online and Social Media Presence

Embed Graph

Concept Life Sciences News and Updates

Andy Scott to speak at Microcalorimetry Virtual Meeting – 12th November

Our Head of Bioassay Development and Screening Andrew Scott will be speaking at Malvern Panalytical‘s Microcalorimetry Virtual Meeting (12th November, 9am GMT). The meeting will provide an overview of the latest Microcalorimetry technology and information on how to use Microcalorimetry to advance…

Concept Life Sciences Host Discussion Group at The Scale-up of Chemical Processes Event

Concept Life Sciences are attending Scientific Update ‘The Scale-up of Chemical Processes’ virtual event on 19th – 21st October 2020. As part of the event we are hosting a discussion group on 21st October at 2pm BST. The discussion group will focus on ‘What’s next? Managing risk and return on …

Concept Life Sciences Supports Malvern Panalytical OmniTrust Launch

Malvern Panalytical will unveil OmniTrust, a new suite of data integrity solutions, at a live online event on 13 October. OmniTrust delivers integrated access, audit, and system validation services across a range of Malvern Panalytical instruments. This provides a common approach for compliance with…

New Webinar: Fragment Screening

In this webinar we explore how we combine Biophysical Screening technology with our state-of-the-art Biophysical Fragment Collection to enhance success rate and speed of delivery of FBDD programmes. Concept Life Sciences’ Scientific Leaders Dr’s Tom Pesnot, Andrew Scott and Tilly Bingham discuss …

Concept Welcomes Empyrean X-Ray Diffractometer

Concept Life Sciences is excited to strengthen its analytical service provision by welcoming a new 3rd generation Empyrean X-Ray diffractometer (Malvern Panalytical). The acquisition of the Empyrean instrument broadens the portfolio of services available to our clients and further deepens the partne…

Concept Life Sciences Announces The Expansion of GXP portfolio with the addition of GLP NMR & QNMR

Concept Life Sciences has the knowledge, skills and capacity to offer a range of solutions to help our clients with regulated & non-regulated analytical work. These analytical services support our GMP manufacturing batch release (CoA as a deliverable) and our process R&D programs (method dev…
Show more

Concept Life Sciences Blogs

The Call for Posters is now open!

We are pleased to announce our first call for poster submissions for the Concept Life Sciences GMP Launch event Good Manufacturing Practice (GMP) event on Wednesday 26th February at Discovery Park in Sandwich, Kent. The one-day event that will connect, collaborate and innovate by bringing together k…

Concept Life Sciences announces the sale of asbestos and environmental consulting business REC Limited to Ensafe Consultants.

  11th October 2019 – Concept Life Sciences (“Concept”), the integrated drug discovery & development company today announced the sale of its asbestos and environmental consulting business REC Limited to Ensafe Consultants. Established in 1995, Ensafe is a leading fully independent asbestos consu…

Overcoming the challenges of immuno-oncology drug development: The power of an extensive suite of in vitro human immunology data

In recent years, we’ve seen a surge of investment in immuno-oncology (IO) drug development, despite there being a number of unique challenges to face in this field. One particular challenge sees developers having to contend with a highly complex tumour micro-environment (TME), The post Overcoming th…

Concept Life Sciences (Edinburgh) Consultant and Histology Chief Technical Officer Co-Publishes Cancer Cell Paper: Human Tumour-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets

Research by Mike Millar consultant and (Histology Chief Technical Officer) at Concept Life Sciences (Edinburgh) has published in Cancer Cell. This was a multi group collaborative effort led by Dr Luca Cassetta (Post-Doctoral Researcher) and Prof. Jeff Pollard (Director, Centre for Reproductive Healt…

Why it’s crucial to understand the limitations of in vivo preclinical models in immuno-oncology drug development

Drug developers are uncovering a wealth of new therapeutic opportunities in immuno-oncology (IO). However, bringing new treatments to market is proving to be particularly challenging in this field. A major reason for this is the extreme difficulty in predicting clinical success using data generated …

Do you have the range of expertise needed to succeed in immuno-oncology drug discovery?

Immuno-oncology (IO) has transformed our approach to treating cancer, ushering in a vast range of drug development opportunities. Despite this, many companies struggle to capitalise on the huge potential of this field. This is because IO raises unique developmental challenges, such as predicting imm…
Show more

Concept Life Sciences Frequently Asked Questions

  • When was Concept Life Sciences founded?

    Concept Life Sciences was founded in 2014.

  • Who are Concept Life Sciences key executives?

    Concept Life Sciences's key executives are Mark Carnegie-Brown, Ben Cliff and Steven Woolley.

  • How many employees does Concept Life Sciences have?

    Concept Life Sciences has 719 employees.

  • Who are Concept Life Sciences competitors?

    Competitors of Concept Life Sciences include Bioduro-Sundia, SAI Life Sciences and NuChem Therapeutics.

  • Where is Concept Life Sciences headquarters?

    Concept Life Sciences headquarters is located at Alderley Park, Congleton Rd, Alderley Edge.

  • Where are Concept Life Sciences offices?

    Concept Life Sciences has offices in Alderley Edge, Bar Hill, Bradford, Derbyshire and in 2 other locations.

  • How many offices does Concept Life Sciences have?

    Concept Life Sciences has 6 offices.